NEURONETICS ($STIM) posted quarterly earnings results on Tuesday, March 4th. The company reported earnings of -$0.33 per share, missing estimates of -$0.25 by $0.08. The company also reported revenue of $22,490,000, beating estimates of $20,026,680 by $2,463,320.
You can see Quiver Quantitative's $STIM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NEURONETICS Insider Trading Activity
NEURONETICS insiders have traded $STIM stock on the open market 13 times in the past 6 months. Of those trades, 2 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $STIM stock by insiders over the last 6 months:
- KEITH J SULLIVAN (President and CEO) has made 0 purchases and 3 sales selling 91,366 shares for an estimated $363,690.
- STEPHEN FURLONG (EVP, CFO and Treasurer) has made 0 purchases and 4 sales selling 44,356 shares for an estimated $162,451.
- WILLIAM ANDREW MACAN (EVP, GC, CCO and CS) has made 0 purchases and 4 sales selling 34,651 shares for an estimated $132,301.
- ROBERT CASCELLA purchased 100,000 shares for an estimated $75,000
- GLENN P MUIR purchased 25,000 shares for an estimated $20,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NEURONETICS Hedge Fund Activity
We have seen 18 institutional investors add shares of NEURONETICS stock to their portfolio, and 47 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARCHON CAPITAL MANAGEMENT LLC removed 2,473,269 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $1,879,189
- SILVERCREST ASSET MANAGEMENT GROUP LLC removed 2,387,418 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $1,813,960
- KENT LAKE PR LLC removed 2,077,848 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $3,345,335
- CANNELL CAPITAL LLC removed 1,314,266 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,115,968
- FIRST WASHINGTON CORP removed 1,274,540 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $968,395
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC removed 1,039,009 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $789,439
- G2 INVESTMENT PARTNERS MANAGEMENT LLC removed 681,461 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $517,774
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NEURONETICS Government Contracts
We have seen $299,400 of award payments to $STIM over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- NEW TMS TRANSCRANIAL MAGNETIC STIMULATION: $268,800
- 644-NEURONETICS TRANSCRANIAL MAGNETIC STIMULATORS PREVENTATIVE MAINTENANCE: $11,000
- NEURONETICS NEUROSTAR TMS THERAPY SYSTEM: $9,800
- HIGHLY SPECIALIZED HOSPITAL EQUIPMENT SERVICE AGREEMENT.: $4,900
- THERAPEUTIC MAGNETIC SYSTEM ANNUAL MAINT MODEL # 81-00315-000: $4,900
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
